Posted by jrbecker on March 29, 2006, at 8:37:31
article excerpt...
"BETTER ANTIDEPRESSANT?
The deal with Servier gives Novartis U.S. rights to agomelatine, a Phase III investigational drug for the treatment of major depressive disorder, which may have advantages over existing treatments.
Agomelatine has been filed for approval in Europe but Novartis will need to conduct a clinical trial program in the United States, which analysts said suggested sales were still a number of years away.
Industry analysts at Kepler Equities said agomelatine appeared to have similar efficacy to other antidepressants such as Wyeth's Effexor and GlaxoSmithKline's Paxil, but may have fewer side effects.
"The antidepressant market is crowded, so ultimate sales of agomelatine for Novartis will depend on the success of its clinical trial program," Kepler said in a note." "
poster:jrbecker
thread:625983
URL: http://www.dr-bob.org/babble/20060329/msgs/625983.html